Research Topics
Genomes and Genes
| R PietersSummaryAffiliation: Erasmus MC Country: The Netherlands Publications
| Collaborators
|
Detail Information
Publications
Asparagine synthetase expression is linked with L-asparaginase resistance in TEL-AML1-negative but not TEL-AML1-positive pediatric acute lymphoblastic leukemiaWendy A G Stams
Erasmus Medical Ceneter/University Medical Center Rotterdam/Sophia Children's Hospital, Division of Pediatric Oncology/Hematology, Dr Molewaterplein 60, 3015 GJ Rotterdam, The Netherlands
Blood 105:4223-5. 2005..009). We conclude that resistance to l-asparaginase and relapse risk are associated with high expression of AS in TEL-AML1-negative but not TEL-AML1-positive B-lineage ALL...
Biology and treatment of acute lymphoblastic leukemiaRob Pieters
Department of Pediatric Oncology and Hematology, Erasmus MC Sophia Children s Hospital, Dr Molewaterplein 60, Rotterdam, The Netherlands
Pediatr Clin North Am 55:1-20, ix. 2008..This article discusses the factors used in risk stratification and the treatment of pediatric ALL...
A treatment protocol for infants younger than 1 year with acute lymphoblastic leukaemia (Interfant-99): an observational study and a multicentre randomised trialRob Pieters
Dutch Childhood Oncology Group DCOG, Netherlands Erasmus MC Sophia Children s Hospital, Rotterdam, Netherlands
Lancet 370:240-50. 2007..We also did a randomised trial to establish the value of a late intensification course...
Pharmacokinetics, pharmacodynamics, efficacy, and safety of a new recombinant asparaginase preparation in children with previously untreated acute lymphoblastic leukemia: a randomized phase 2 clinical trialRob Pieters
Department of Pediatric Oncology and Hematology, Erasmus MC Sophia Children s Hospital, Rotterdam, The Netherlands
Blood 112:4832-8. 2008..This trial was registered at http://www.controlled-trials.com as no. ISRCTN 75734403...
Molecular pharmacodynamics in childhood leukemiaR Pieters
University Medical Center Rotterdam, Sophia Childrens Hospital, Pediatric Oncology/Hematology, Rotterdam, The Netherlands
Int J Hematol 78:402-13. 2003
Biology and treatment of acute lymphoblastic leukemiaRob Pieters
Department of Pediatric Oncology and Hematology, Erasmus MC Sophia Children s Hospital, Dr Molewaterplein 60, Rotterdam, The Netherlands
Hematol Oncol Clin North Am 24:1-18. 2010..This article discusses the factors used in risk stratification and the treatment of pediatric ALL...
Infant acute lymphoblastic leukemia: Lessons learned and future directionsRob Pieters
Erasmus MC Sophia Children s Hospital, Dr Molewaterplein 60, 3015GJ, Rotterdam, The Netherlands
Curr Hematol Malig Rep 4:167-74. 2009..New genetic and epigenetic insights into the biology of MLL-rearranged ALL suggest new possibilities for therapies...
[Acute lymphoblastic leukaemia in children and adolescents: chance of cure now higher than 80%]Rob Pieters
Erasmus MC Sophia Kinderziekenhuis, afd Kinderoncologie hematologie, The Netherlands
Ned Tijdschr Geneeskd 154:A1577. 2010..It is anticipated that genomic research will lead to better classification and to more personalized therapy for individual patients...
L-asparaginase treatment in acute lymphoblastic leukemia: a focus on Erwinia asparaginaseRob Pieters
Erasmus MC Sophia Children s Hospital, Rotterdam, Netherlands
Cancer 117:238-49. 2011..This article provides an overview of available evidence for optimal use of Erwinia asparaginase in the treatment of ALL...
EVI1 overexpression in distinct subtypes of pediatric acute myeloid leukemiaB V Balgobind
Department of Pediatric Oncology Hematology, Erasmus MC Sophia Children s Hospital, Rotterdam, The Netherlands
Leukemia 24:942-9. 2010..Further research should explain the role of EVI1+ in disease biology in these cases. Remarkably, no 3q26 abnormalities were identified in EVI1+ pediatric AML...
Multidrug resistance genes in infant acute lymphoblastic leukemia: Ara-C is not a substrate for the breast cancer resistance proteinR W Stam
Department of Pediatric Oncology Hematology, Erasmus MC Sophia Children s Hospital, Rotterdam, The Netherlands
Leukemia 18:78-83. 2004..8/T6400, also did not modulate Ara-C cytotoxicity. Therefore, we conclude that Ara-C is not a substrate for BCRP and that MDR proteins do not play a significant role in drug resistance in infant ALL...
Prognostic significance of molecular-cytogenetic abnormalities in pediatric T-ALL is not explained by immunophenotypic differencesM van Grotel
Department of Pediatric Oncology Hematology, Erasmus University Medical Center Sophia Children s Hospital, Rotterdam, The Netherlands
Leukemia 22:124-31. 2008..Most cases with lower TAL1 levels were HOX11L2 or CALM-AF10 positive. NOTCH1 mutations did not predict for outcome. Classification into T-cell developmental subgroups was not predictive for outcome...
Hypermethylation of specific microRNA genes in MLL-rearranged infant acute lymphoblastic leukemia: major matters at a micro scaleD J P M Stumpel
Department of Pediatric Oncology Hematology, Erasmus Medical Center, Sophia Children s Hospital, Rotterdam, The Netherlands
Leukemia 25:429-39. 2011..In this study, we provide additional evidence that they should be tested for their efficacy in MLL-rearranged infant ALL in in vivo models...
mRNA expression levels of (co)chaperone molecules of the glucocorticoid receptor are not involved in glucocorticoid resistance in pediatric ALLW J E Tissing
Division of Pediatric Oncology/Hematology, Erasmus MC-Sophia Childrens Hospital, University Medical Center Rotterdam, The Netherlands
Leukemia 19:727-33. 2005..GC resistance in childhood ALL cannot be attributed to different mRNA expression levels of the investigated (co)chaperone molecules involved in GC binding and transport to the nucleus...
Differential expression of p73 isoforms in relation to drug resistance in childhood T-lineage acute lymphoblastic leukaemiaM Meier
Department of Paediatric Oncology/Haematology, Erasmus MC/Sophia Children's Hospital, Erasmus University Medical Centre, Rotterdam, The Netherlands
Leukemia 20:1377-84. 2006..Our results suggest that childhood T-ALL is associated with a high expression of DeltaTA-p73. These isoforms may play a role in cellular resistance to DNA-damaging drugs in children at initial diagnosis of T-ALL...
Prognostic significance of minimal residual disease in infants with acute lymphoblastic leukemia treated within the Interfant-99 protocolV H J van der Velden
Department of Immunology, Erasmus MC, University Medical Center, Rotterdam, The Netherlands
Leukemia 23:1073-9. 2009..These data indicate that MRD diagnostics has added value for recognition of risk groups in infant ALL and that MRD diagnostics can be used for treatment intervention in infant ALL as well...
Expression levels of TEL, AML1, and the fusion products TEL-AML1 and AML1-TEL versus drug sensitivity and clinical outcome in t(12;21)-positive pediatric acute lymphoblastic leukemiaWendy A G Stams
Division of Pediatric Oncology/Hematology, Erasmus MC, Sophia Children's Hospital, Rotterdam, Netherlands
Clin Cancer Res 11:2974-80. 2005..CONCLUSION: High AML1-TEL expression is an independent poor prognostic factor in t(12;21)+ childhood ALL...
Endocrine late sequelae in long-term survivors of childhood non-Hodgkin lymphomaM van Waas
Department of Pediatric Oncology Hematology, Erasmus Medical Center, Rotterdam, The Netherlands
Ann Oncol 23:1626-32. 2012..Aim of this study was to investigate the long-term endocrine effects of treatment of childhood non-Hodgkin lymphoma (NHL)...
MDR1 gene-related clonal selection and P-glycoprotein function and expression in relapsed or refractory acute myeloid leukemiaM M van den Heuvel-Eibrink
Department of Hematology, University Hospital, Rotterdam, The Netherlands
Blood 97:3605-11. 2001..Blood. 2001;97:3605-3611)..
Polymorphisms in genes involved in vincristine pharmacokinetics or pharmacodynamics are not related to impaired motor performance in children with leukemiaA Hartman
Department of Pediatric Oncology Hematology, Erasmus MC Sophia Children s Hospital, PO Box 2060, 3000 CB Rotterdam, The Netherlands
Leuk Res 34:154-9. 2010..Impaired motor performance in children who completed treatment for acute lymphoblastic leukemia (ALL) may be related to polymorphisms of the metabolising gene CYP3A5 or vincristine toxicity related genes MDR-1 and MAPT...
NOTCH1 and/or FBXW7 mutations predict for initial good prednisone response but not for improved outcome in pediatric T-cell acute lymphoblastic leukemia patients treated on DCOG or COALL protocolsL Zuurbier
Department of Pediatric Oncology Hematology, Sophia Children s Hospital, Erasmus University Medical Center, Rotterdam, The Netherlands
Leukemia 24:2014-22. 2010..Comparing our data with other studies, we conclude that the prognostic significance for NOTCH1/FBXW7 mutations is not consistent and may depend on the treatment protocol given...
Inhibition of glycolysis modulates prednisolone resistance in acute lymphoblastic leukemia cellsEsther Hulleman
Department of Pediatric Oncology and Hematology, Erasmus Medical Center Sophia Children s Hospital, University Medical Center, Rotterdam, The Netherlands
Blood 113:2014-21. 2009..Together, these findings indicate the importance of the glycolytic pathway in glucocorticoid resistance in ALL and suggest that targeting glycolysis is a viable strategy for modulating prednisolone resistance in ALL...
Gene-expression patterns in drug-resistant acute lymphoblastic leukemia cells and response to treatmentAmy Holleman
Division of Pediatric Oncology-Hematology, Erasmus University Medical Center, Sophia Children's Hospital, Rotterdam, The Netherlands
N Engl J Med 351:533-42. 2004..CONCLUSIONS: Differential expression of a relatively small number of genes is associated with drug resistance and treatment outcome in childhood ALL...
Relation between genetic variants of the ataxia telangiectasia-mutated (ATM) gene, drug resistance, clinical outcome and predisposition to childhood T-lineage acute lymphoblastic leukaemiaM Meier
Department of Paediatric Oncology Haematology, Erasmus MC Sophia Children s Hospital, Erasmus University Medical Centre, Rotterdam, The Netherlands
Leukemia 19:1887-95. 2005..05). The association between five coding ATM alterations in T-ALL, their germline presence, white blood cell count and unfavourable outcome may point to a role for ATM in the development of T-ALL in these children...
Silencing of the tumor suppressor gene FHIT is highly characteristic for MLL gene rearranged infant acute lymphoblastic leukemiaR W Stam
Erasmus MC/Sophia Children's Hospital, Department of Pediatric Oncology/Hematology, Rotterdam, The Netherlands
Leukemia 20:264-71. 2006..These observations imply that suppression of FHIT may be required for the development of MLL, and provide new insights into leukemogenesis and therapeutic possibilities for MLL...
High BRE expression in pediatric MLL-rearranged AML is associated with favorable outcomeB V Balgobind
Pediatric Oncology Hematology, Erasmus MC Sophia Children s Hospital, Rotterdam, The Netherlands
Leukemia 24:2048-55. 2010..Although further investigation for the role of BRE in leukemogenesis and outcome is warranted, high BRE expression is an independent prognostic factor for pRFS in pediatric AML...
Cooperative genetic defects in TLX3 rearranged pediatric T-ALLP van Vlierberghe
Department of Pediatric Oncology Hematology, Erasmus MC Sophia Children s Hospital, Rotterdam, The Netherlands
Leukemia 22:762-70. 2008..This study provides a genome-wide overview of copy number changes in TLX3 rearranged T-ALL and offers great new challenges for the identification of new target genes that may play a role in the pathogenesis of T-ALL...
Components of the metabolic syndrome in 500 adult long-term survivors of childhood cancerM van Waas
Department of Paediatric Oncology Haematology, Erasmus Medical Centre, Sophia Children s Hospital, Rotterdam, The Netherlands
Ann Oncol 21:1121-6. 2010..A cluster of abnormalities that contribute to the metabolic syndrome may be expressed at a higher level and therefore result in an increased risk for diabetes mellitus and cardiovascular diseases...
A new recurrent 9q34 duplication in pediatric T-cell acute lymphoblastic leukemiaP van Vlierberghe
Erasmus MC/Sophia Children's Hospital, Department of Pediatric Oncology/Hematology, Rotterdam, The Netherlands
Leukemia 20:1245-53. 2006..We showed that both of these genetic abnormalities occur independently from this newly identified 9q34 duplication...
MDR1 expression in poor-risk acute myeloid leukemia with partial or complete monosomy 7M M van den Heuvel-Eibrink
Department of Hematology, University Hospital and Erasmus University, Rotterdam, The Netherlands
Leukemia 15:398-405. 2001..We conclude that MDR1 expression in -7/7q- AML patients is upregulated at transcriptional, but not at translational level, suggesting that mechanisms other than MDR1 are responsible for the poor prognosis in these patients...
Specific promoter methylation identifies different subgroups of MLL-rearranged infant acute lymphoblastic leukemia, influences clinical outcome, and provides therapeutic optionsDominique J P M Stumpel
Department of Pediatric Oncology Hematology, Erasmus Medical Center Sophia Children s Hospital, Rotterdam, The Netherlands
Blood 114:5490-8. 2009..Therefore, inhibition of aberrant DNA methylation may be an important novel therapeutic strategy for MLL-rearranged ALL in infants...
Germline variation in the MTHFR and MTRR genes determines the nadir of bone density in pediatric acute lymphoblastic leukemia: a prospective studyM L te Winkel
Department of Pediatric Oncology Hematology, Erasmus MC Sophia Children s Hospital, Rotterdam, The Netherlands
Bone 48:571-7. 2011..This study aims to identify folate-metabolism-related genetic risk factors for low bone mineral density (BMD) during/after pediatric acute lymphoblastic leukemia (ALL) treatment...
Differential expression and prognostic significance of SOX genes in pediatric medulloblastoma and ependymoma identified by microarray analysisJudith M de Bont
Department of Pediatric Oncology and Hematology, Erasmus MC Sophia Children s Hospital, University Medical Center Rotterdam, Rotterdam, The Netherlands
Neuro Oncol 10:648-60. 2008....
Aurora kinases in childhood acute leukemia: the promise of aurora B as therapeutic targetS A Hartsink-Segers
1 Department of Pediatric Oncology Hematology, Erasmus MC Sophia Children s Hospital, Rotterdam, The Netherlands 2 Kids Cancer Kinome Consortium, Villejuif, France
Leukemia 27:560-8. 2013....
Frequency of WT1 and 11p15 constitutional aberrations and phenotypic correlation in childhood Wilms tumour patientsH Segers
Department of Pediatric Oncology Hematology, Erasmus MC Sophia Children s Hospital, Rotterdam, The Netherlands
Eur J Cancer 48:3249-56. 2012..Therefore, we investigated the frequency of constitutional aberrations in combination with phenotype...
Connectivity mapping identifies HDAC inhibitors for the treatment of t(4;11)-positive infant acute lymphoblastic leukemiaD J P M Stumpel
Department of Pediatric Oncology Hematology, Erasmus Medical Center, Sophia Children s Hospital, Rotterdam, The Netherlands
Leukemia 26:682-92. 2012..Given the presented potential of HDAC inhibitors to target important proto-oncogenes including the leukemia-specific MLL fusion in vitro, these agents should urgently be tested in in vivo models and subsequent clinical trials...
Discovery of new microRNAs by small RNAome deep sequencing in childhood acute lymphoblastic leukemiaD Schotte
Department of Pediatric Oncology and Hematology, Erasmus MC Sophia Children s Hospital, Erasmus University Medical Center, Rotterdam, The Netherlands
Leukemia 25:1389-99. 2011..36, P = 0.007). The identification of >1000 miR genes expressed in different types of ALL forms a comprehensive repository for further functional studies that address the role of miRNAs in the biology of ALL...
Incidence of additional genetic changes in the TEL and AML1 genes in DCOG and COALL-treated t(12;21)-positive pediatric ALL, and their relation with drug sensitivity and clinical outcomeW A G Stams
Erasmus MC, Sophia Children's Hospital, Erasmus University Medical Center Rotterdam, Division of Pediatric Oncology/Hematology, Rotterdam, The Netherlands
Leukemia 20:410-6. 2006..78, 95% CI 1.45-23.0; P=0.01) is an independent prognostic factor in DCOG- and COALL-treated t(12;21)-positive ALL...
Outcome in children with Down's syndrome and acute lymphoblastic leukemia: role of IKZF1 deletions and CRLF2 aberrationsT D Buitenkamp
Department of Pediatric Oncology Hematology, Erasmus MC Sophia Children s Hospital, Rotterdam, The Netherlands
Leukemia 26:2204-11. 2012..05; P=0.001). Neither CRLF2 nor JAK2 were predictors for worse prognosis. If confirmed in prospective series, IKZF1 deletions may be used for risk-group stratification in DS ALL...
NKL homeobox genes in leukemiaI Homminga
Department of Pediatric Oncology Hematology, Erasmus MC Sophia Children s Hospital, Rotterdam, The Netherlands
Leukemia 26:572-81. 2012..Identification of a potential common leukemogenic NKL downstream pathway will provide a promising subject for future studies...
MicroRNAs in acute leukemia: from biological players to clinical contributorsD Schotte
Department of Pediatric Oncology and Hematology, Erasmus MC Sophia Children s Hospital, University Medical Center Rotterdam, Rotterdam, The Netherlands
Leukemia 26:1-12. 2012..However, emerging knowledge about the biology of miRNAs in leukemia may result into a role for these miRNAs in the diagnosis and treatment of acute leukemia...
The heterogeneity of pediatric MLL-rearranged acute myeloid leukemiaB V Balgobind
Department of Pediatric Oncology Hematology, Erasmus MC Sophia Children s Hospital, Rotterdam, The Netherlands
Leukemia 25:1239-48. 2011..To achieve further improvements in outcome, unraveling the biology of MLL-rearranged pediatric AML is warranted...
Identification of new microRNA genes and aberrant microRNA profiles in childhood acute lymphoblastic leukemiaD Schotte
Department of Pediatric Oncology and Hematology, Erasmus MC Sophia Children s Hospital, University Medical Center Rotterdam, Rotterdam, The Netherlands
Leukemia 23:313-22. 2009..In conclusion, we identified new miRNA genes and showed that miRNA expression profiles are ALL subtype-specific rather than linked to the differentiation stadium associated with these subtypes...
Patient stratification based on prednisolone-vincristine-asparaginase resistance profiles in children with acute lymphoblastic leukemiaM L den Boer
Department of Pediatric Oncology and Hematology, Erasmus MC Sophia Children s Hospital, PO Box 2060, 3000 CB Rotterdam, The Netherlands
J Clin Oncol 21:3262-8. 2003....
Pharmacokinetic, pharmacodynamic and intracellular effects of PEG-asparaginase in newly diagnosed childhood acute lymphoblastic leukemia: results from a single agent window studyI M Appel
Department of Pediatric Oncology Hematology, Erasmus MC Sophia Children s Hospital, Erasmus University Medical Center, Rotterdam, The Netherlands
Leukemia 22:1665-79. 2008..This may be explained by the rapid removal of apoptotic cells from the circulation in vivo. One additional dose of PEG-asparaginase upfront ALL treatment did not lead to other severe toxicities...
Favorable prognostic impact of NPM1 gene mutations in childhood acute myeloid leukemia, with emphasis on cytogenetically normal AMLI H I M Hollink
Department of Pediatric Oncology and Hematology, Erasmus MC Sophia Children s Hospital, Rotterdam, The Netherlands
Leukemia 23:262-70. 2009..However, in NPM1 wild-type CN-AML, FLT3/ITD-positive patients had a significantly worse outcome (pEFS 48 vs 18%; P<0.001). We conclude that NPM1 mutations confer a favorable prognosis in childhood AML and in CN-AML in particular...
Resistance to different classes of drugs is associated with impaired apoptosis in childhood acute lymphoblastic leukemiaAmy Holleman
Erasmus MC/Sophia Children's Hospital, Pediatric Oncology/Hematology, Rm Sp2456, Dr Molewaterplein 60, PO Box 2060, 3000 CB Rotterdam, The Netherlands
Blood 102:4541-6. 2003..This leads to decreased activation of apoptotic parameters in resistant cases of pediatric ALL...
Outcome of congenital acute lymphoblastic leukemia treated on the Interfant-99 protocolMarieke H van der Linden
Erasmus MC Sophia Children s Hospital, Rotterdam, The Netherlands
Blood 114:3764-8. 2009..This trial was registered at www.clinicaltrials.gov as no. NCT 00015873, and at www.controlled-trials.com as no. ISRCTN24251487...
Genomewide identification of prednisolone-responsive genes in acute lymphoblastic leukemia cellsWim J E Tissing
Department of Pediatric Oncology Hematology, Erasmus MC Sophia Children s Hospital, Dr Molewaterplein 60, 3015 GJ Rotterdam, The Netherlands
Blood 109:3929-35. 2007..Biologic characterization of these genes and pathways might elucidate the action of glucocorticoids in ALL cells, possibly suggesting causes of glucocorticoid resistance and new potential targets for therapy...
The recurrent SET-NUP214 fusion as a new HOXA activation mechanism in pediatric T-cell acute lymphoblastic leukemiaPieter Van Vlierberghe
Department of Pediatric Oncology Hematology, Erasmus Medical Center Sophia Children s Hospital, Rotterdam, The Netherlands
Blood 111:4668-80. 2008..We conclude that SET-NUP214 may contribute to the pathogenesis of T-ALL by enforcing T-cell differentiation arrest...
Novel prognostic subgroups in childhood 11q23/MLL-rearranged acute myeloid leukemia: results of an international retrospective studyBrian V Balgobind
Department of Pediatric Oncology Hematology, Erasmus MC Sophia Children s Hospital, Rotterdam, The Netherlands
Blood 114:2489-96. 2009..Screening for these translocation partners is needed for accurate treatment stratification at diagnosis...
Targeting FLT3 in primary MLL-gene-rearranged infant acute lymphoblastic leukemiaRonald W Stam
Erasmus Medical Center/Sophia Children's Hospital, Pediatric Oncology/Hematology, Rotterdam, The Netherlands
Blood 106:2484-90. 2005..Thus, PKC412-induced apoptosis in infant MLL cells is unlikely to be a consequence of FLT3 inhibition alone but may involve inhibition of multiple other kinases by this drug...
Improved flow cytometric detection of minimal residual disease in childhood acute lymphoblastic leukemiaB Denys
Department of Immunology, Erasmus MC, University Medical Center, Rotterdam, The Netherlands
Leukemia 27:635-41. 2013..In conclusion, 6-color FCM significantly improves MRD analysis in ALL but remains less sensitive than PCR-based MRD-diagnostics...
The hunting of targets: challenge in miRNA researchF Akbari Moqadam
Department of Pediatric Oncology and Hematology, Erasmus MC Sophia Children s Hospital, University Medical Center Rotterdam, Rotterdam, The Netherlands
Leukemia 27:16-23. 2013....
L-asparaginase-induced severe necrotizing pancreatitis successfully treated with percutaneous drainageP C Top
Department of Pediatric Oncology/Hematology, Erasmus MC-Sophia Children's Hospital, Rotterdam, The Netherlands
Pediatr Blood Cancer 44:95-7. 2005..We present a pediatric patient with leukemia and a severe, L-asparaginase-induced necrotizing pancreatitis, treated successfully with percutaneous drainage used to flush the infected necrotic parts...
Molecular determinants of glucocorticoid sensitivity and resistance in acute lymphoblastic leukemiaW J E Tissing
University Hospital Rotterdam/Sophia Children's Hospital, Department of Paediatric Oncology/Hematology, Rotterdam, The Netherlands
Leukemia 17:17-25. 2003....
Posterior reversible encephalopathy syndrome in childhood cancerP de Laat
Department of Pediatric Oncology Hematology, Erasmus MC Sophia Children s Hospital, University Medical Center, Rotterdam, The Netherlands
Ann Oncol 22:472-8. 2011..Posterior reversible encephalopathy syndrome (PRES) is characterized by seizures, headaches, altered mental status, cortical blindness and typical transient lesions on magnetic resonance imaging...
Ultrafine but not fine particulate matter causes airway inflammation and allergic airway sensitization to co-administered antigen in miceC de Haar
Department of Immunotoxicology, Institute for Risk Assessment Sciences, Utrecht University, Utrecht, The Netherlands
Clin Exp Allergy 36:1469-79. 2006..The PM adjuvant activity on allergic sensitization is a possible mechanism of action involved, and the induction of airway inflammation is suggested to be of importance in PM-induced adjuvant activity...
Decrease in peripheral muscle strength and ankle dorsiflexion as long-term side effects of treatment for childhood cancerAnnelies Hartman
Department of Pediatric Oncology Hematology, Erasmus MC Sophia Children s Hospital, Rotterdam, The Netherlands
Pediatr Blood Cancer 50:833-7. 2008....
Increased total-Tau levels in cerebrospinal fluid of pediatric hydrocephalus and brain tumor patientsJudith M de Bont
Erasmus MC, University Medical Center, Sophia Children s Hospital, Rotterdam, The Netherlands
Eur J Paediatr Neurol 12:334-41. 2008..Ongoing studies should determine whether these neurodegenerative markers in CSF can be used to monitor neuronal and axonal degeneration in these patients during therapy and long-term follow up...
Inhibin B is superior to FSH as a serum marker for spermatogenesis in men treated for Hodgkin's lymphoma with chemotherapy during childhoodRobert D van Beek
Department of Pediatric Oncology Hematology, Erasmus MC Sophia Children s Hospital, Room Sp3435, PO Box 2060, 3000 CB Rotterdam, The Netherlands
Hum Reprod 22:3215-22. 2007....
Various components of the insulin-like growth factor system in tumor tissue, cerebrospinal fluid and peripheral blood of pediatric medulloblastoma and ependymoma patientsJudith M de Bont
Department of Pediatric Oncology and Hematology, Erasmus MC University Medical Center, Sophia Children s Hospital, Rotterdam, The Netherlands
Int J Cancer 123:594-600. 2008..Larger studies should be conducted to validate the predictive values of the levels of intact IGFBP-3 and proteolytic fragments in CSF in the follow-up of medulloblastomas...
A subtype of childhood acute lymphoblastic leukaemia with poor treatment outcome: a genome-wide classification studyMonique L den Boer
Department of Paediatric Oncology and Haematology, Erasmus MC Sophia Children s Hospital, University Medical Centre, Rotterdam, Netherlands
Lancet Oncol 10:125-34. 2009..25% of precursor B-ALL cases are genetically unclassified and have intermediate prognosis. We aimed to use a genome-wide study to improve prognostic classification of ALL in children...
Effect of polymorphisms in folate-related genes on in vitro methotrexate sensitivity in pediatric acute lymphoblastic leukemiaRobert de Jonge
Department of Clinical Chemistry and Pediatric Oncology Hematology, Erasmus MC, Rm L 102, POB 2040, 3000 CA Rotterdam, The Netherlands
Blood 106:717-20. 2005..SHMT1 1420TT homozygotes only showed decreased MTX sensitivity in the TSI(50, cont). In conclusion, polymorphisms in the folate-related genes MTHFR, MTRR, and SHMT1 are related to MTX resistance in pediatric patients with ALL...
Medical end-of-life decisions for children in the NetherlandsAstrid M Vrakking
Department of Public Health, Erasmus MC and Erasmus MC Sophia, Children s Hospital, University Medical Center Rotterdam, Rotterdam, The Netherlands
Arch Pediatr Adolesc Med 159:802-9. 2005..Most end-of-life decision-making studies have, until now, involved either the general population or newborn infants...
L-Asparaginase and the effect of age on coagulation and fibrinolysis in childhood acute lymphoblastic leukemiaInge M Appel
Department of Pediatrics, Div Oncology Hematology, Erasmus MC Sophia Children s Hospital, Rotterdam, The Netherlands
Thromb Haemost 100:330-7. 2008..In conclusion, a more severe decline of anticoagulant and fibrinolytic parameters in children between 11 and 16 years of age underline that these children are at higher risk of thrombosis during ALL induction treatment...
The effect of cytostatic drug treatment on intestine-specific transcription factors Cdx2, GATA-4 and HNF-1alpha in miceBarbara A E de Koning
Laboratory of Pediatrics, Division of Pediatric Gastro enterology, Erasmus MC Sophia Children s Hospital, Rotterdam, The Netherlands
Cancer Chemother Pharmacol 57:801-10. 2006....
Genetic variations in the glucocorticoid receptor gene are not related to glucocorticoid resistance in childhood acute lymphoblastic leukemiaWim J E Tissing
Department of Pediatric Oncology/Hematology, Erasmus Medical Center/Sophia Children's Hospital, Rotterdam, The Netherlands
Clin Cancer Res 11:6050-6. 2005..The higher incidence of the N363S minor allele and the lower incidence of the ER22/23EK minor allele in our ALL population as compared with a normal population warrants further research...
Biological background of pediatric medulloblastoma and ependymoma: a review from a translational research perspectiveJudith M de Bont
Department of Pediatric Oncology and Hematology, Erasmus MC Sophia Children s Hospital, Rotterdam, The Netherlands
Neuro Oncol 10:1040-60. 2008....
Impact of two independent bone marrow samples on minimal residual disease monitoring in childhood acute lymphoblastic leukaemiaVincent H J van der Velden
Department of Immunology, Erasmuc MC, Erasmus University Medical Center, The Netherlands
Br J Haematol 133:382-8. 2006..Nevertheless, MRD-based risk group classification can differ between paired BM samples, mainly because of variation below the quantitative range of the PCR assay rather than to a different distribution of leukaemic cells within the BM...
Polymorphisms in folate-related genes and risk of pediatric acute lymphoblastic leukemiaRobert de Jonge
Clinical Chemistry, Erasmus University Medical Center, Rotterdam, The Netherlands
Blood 113:2284-9. 2009..2-fold increase in ALL risk (P = .001). For the first time, we associate the RFC1 80G>A and NNMT IVS -151C>T variants to an increased ALL susceptibility...
Towards targeted therapy for infant acute lymphoblastic leukaemiaRonald W Stam
Department of Paediatric Oncology/Haematology, Erasmus MC - Sophia Children's Hospital, Rotterdam, The Netherlands
Br J Haematol 132:539-51. 2006..Here we review the current acquaintance with the biology of infant ALL and describe how this knowledge may lead to innovative therapeutic approaches...
Decrease in motor performance in children with cancer is independent of the cumulative dose of vincristineAnnelies Hartman
Department of Pediatric Oncology Hematology, Erasmus MC Sophia Children s Hospital, Rotterdam, 3000 CB Rotterdam, The Netherlands
Cancer 106:1395-401. 2006....
MicroRNA characterize genetic diversity and drug resistance in pediatric acute lymphoblastic leukemiaDiana Schotte
Erasmus MC Sophia Children s Hospital, Dept of Pediatric Oncology and Hematology, room Sp2456 P O Box 2060, 3000 CB Rotterdam, The Netherlands
Haematologica 96:703-11. 2011..The aim of the current study was to explore which microRNA are unique for seven different subtypes of pediatric acute lymphoblastic leukemia...
Expression of the outcome predictor in acute leukemia 1 (OPAL1) gene is not an independent prognostic factor in patients treated according to COALL or St Jude protocolsAmy Holleman
Department of Pediatric Oncology Hematology, Erasmus MC Sophia Children s Hospital, Erasmus University Medical Center, Dr Molewaterplein 60, 3015 GJ Rotterdam, The Netherlands
Blood 108:1984-90. 2006..In conclusion, OPAL1 expression may not be an independent prognostic feature in childhood ALL, and its previously reported prognostic impact appears to be treatment dependent...
Gene expression profiling-based dissection of MLL translocated and MLL germline acute lymphoblastic leukemia in infantsRonald W Stam
Department of Pediatric Oncology Hematology, Erasmus MC Sophia Children s Hospital, Rotterdam, The Netherlands
Blood 115:2835-44. 2010..These gene expression profiles should provide important novel insights in the complex biology of MLL-rearranged infant ALL and boost our progress in finding novel therapeutic solutions...
Association of high-level MCL-1 expression with in vitro and in vivo prednisone resistance in MLL-rearranged infant acute lymphoblastic leukemiaRonald W Stam
Department of Pediatric Oncology Hematology, Erasmus Medical Center Sophia Children s Hospital, Rotterdam, The Netherlands
Blood 115:1018-25. 2010....
High relapse rate in children with non-advanced nodular lymphocyte predominant Hodgkin's lymphoma (NLPHL or nodular paragranuloma) treated with chemotherapy onlyMartine van Grotel
Department of Pediatric Oncology/Hematology, Erasmus University Medical Center-Sophia Children's Hospital, Rotterdam, The Netherlands
Leuk Lymphoma 47:1504-10. 2006..Moreover, it illustrates that although cure of pediatric NLPHL is feasible with chemotherapy only, high dosages of cytotoxic drugs are necessary as salvage treatment in a relatively high proportion of patients after relapse...
Methotrexate-induced mucositis in mucin 2-deficient miceBarbara A E de Koning
Division of Pediatric Oncology, Laboratory of Pediatrics, Erasmus MC Sophia Children s Hospital, Rotterdam, The Netherlands
J Cell Physiol 210:144-52. 2007..A possible explanation is the mechanism by which Muc2 deficiency may trigger the immune system to release interleukin-10, an anti-inflammatory cytokine before MTX-treatment...
High incidence of t(7;12)(q36;p13) in infant AML but not in infant ALL, with a dismal outcome and ectopic expression of HLXB9Anne R M von Bergh
Department of Clinical Genetics, Erasmus MC, Rotterdam, The Netherlands
Genes Chromosomes Cancer 45:731-9. 2006..The t(7;12) is associated with a poor outcome and an ectopic expression of HLXB9 is commonly involved in this genetic subtype of leukemia...
Microarray-based identification of new targets for specific therapies in pediatric leukemiaMonique L den Boer
Erasmus MC Sophia Children s Hospital, Erasmus University Medical Center, Dept of Pediatric Oncology and Hematology, Dr Molewaterplein 60, 3015 GJ Rotterdam, The Netherlands
Curr Drug Targets 8:761-4. 2007..In this review we will discuss the recent progress that has been made in the use of microarrays for identifying new markers and targets for treatment of acute leukemia in children...
Changes in hypercoagulability by asparaginase: a randomized study between two asparaginasesInge M Appel
Department of Pediatrics, Division of Oncology Hematology, Erasmus MC Sophia Children s Hospital, Rotterdam, The Netherlands
Blood Coagul Fibrinolysis 17:139-46. 2006..coli L-asparaginase-treated patients only...
Alterations in epithelial and mesenchymal intestinal gene expression during doxorubicin-induced mucositis in miceBarbara A E de Koning
Department of Pediatrics, Divisions of Pediatric Oncology, Erasmus MC Sophia Children s Hospital, Rotterdam, The Netherlands
Dig Dis Sci 52:1814-25. 2007..These data suggest that in response to DOX-induced damage, BMP4 and TCF4 are modulated in such a way that homeostasis of the progenitor compartment is partly preserved...
Clustering of hypermethylated genes in neuroblastomaMax M van Noesel
Department of Human Genetics, Academic Medical Center, Amsterdam, The Netherlands
Genes Chromosomes Cancer 38:226-33. 2003..The methylation pattern therefore supports a model in which CpG islands are not randomly targeted by methylation in cancer. Specific transcriptional silencing probably marks genes that can become methylated...
Novel murine B-cell lymphoma/leukemia model to study BCL2-driven oncogenesisJules P P Meijerink
Department of Pediatrics, Division of Oncology Hematology, Erasmus MC Rotterdam Sophia Children s Hospital, NL 3015GE Rotterdam, The Netherlands
Int J Cancer 114:917-25. 2005..In conclusion, our mouse model may prove a valuable tool to identify genes that cooperate in BCL2-enforced lymphoma/leukemogenesis...
The clinical value of follow-up examinations in childhood T-cell acute lymphoblastic leukemia and T-cell non-Hodgkin's lymphomaL Huang
Department of Pediatric Hemato Oncology, Erasmus MC Sophia Children s Hospital, Rotterdam, The Netherlands
Pediatr Blood Cancer 48:468-72. 2007....
Immunobiological diversity in infant acute lymphoblastic leukemia is related to the occurrence and type of MLL gene rearrangementM W J C Jansen
Department of Immunology, Erasmus MC, Rotterdam, The Netherlands
Leukemia 21:633-41. 2007..The high frequency of immature and oligoclonal Ig/TCR rearrangements is probably caused by early (prenatal) oncogenic transformation in immature B-lineage progenitor cells with germline Ig/TCR genes combined with a short latency period...
Contributions of mucosal immune cells to methotrexate-induced mucositisBarbara A E de Koning
Division of Pediatric Oncology, Erasmus MC Sophia Children s Hospital, Dr Molewaterplein 60, PO Box 2060, 3000 GE Rotterdam, The Netherlands
Int Immunol 18:941-9. 2006..We conclude that mucosal immune responses remain resilient during MTX-induced mucositis. Whereas TNF-alpha production may contribute to mucosal damage, IL-10 may regulate by restricting excessive mucositis...
Sensitivity to L-asparaginase is not associated with expression levels of asparagine synthetase in t(12;21)+ pediatric ALLWendy A G Stams
Erasmus MC University Medical Center Rotterdam Sophia Children s Hospital, Division of Pediatric Oncology Hematology, Rotterdam, The Netherlands
Blood 101:2743-7. 2003..Furthermore, we contradict the general thought that leukemic cells specifically lack AS compared with normal bone marrow and blood cells...
Glucocorticoid-induced glucocorticoid-receptor expression and promoter usage is not linked to glucocorticoid resistance in childhood ALLWim J E Tissing
Department of Pediatric Oncology/Hematology, Erasmus MC, Sophia Children's Hospital, University Medical Center Rotterdam, Dr Molewaterplein 60, 3015 GJ Rotterdam, The Netherlands
Blood 108:1045-9. 2006..GC resistance in childhood ALL cannot be attributed to an inability of resistant cells to up-regulate the expression of the GR upon GC exposure, nor to differences in GR promoter usage (at baseline and upon GC exposure)...
The expression of 70 apoptosis genes in relation to lineage, genetic subtype, cellular drug resistance, and outcome in childhood acute lymphoblastic leukemiaAmy Holleman
Department of Pediatric Oncology and Hematology, Erasmus MC Sophia Children s Hospital, Rotterdam, The Netherlands
Blood 107:769-76. 2006..051). In conclusion, ALL subtypes have a unique expression pattern of apoptosis genes and our data suggest that selective genes are linked to cellular drug resistance and prognosis in childhood B-lineage ALL...
Self-limiting sternal tumors of childhood (SELSTOC)M L te Winkel
Department of Pediatric Oncology Hematology, Erasmus MC, Sophia Children s Hospital, Rotterdam, The Netherlands
Pediatr Blood Cancer 55:81-4. 2010..Because a sternal mass is often alarming, it is important to identify the clinical features of benign processes...
A randomized trial investigating an exercise program to prevent reduction of bone mineral density and impairment of motor performance during treatment for childhood acute lymphoblastic leukemiaA Hartman
Department of Paediatric Oncology Haematology, Erasmus MC Sophia Children s Hospital, Rotterdam, The Netherlands
Pediatr Blood Cancer 53:64-71. 2009..We performed a randomized study investigating whether an exercise program could prevent these side effects...
No adverse effect of vincristine on handwriting in children after completion of therapyA Hartman
Department of Pediatric Oncology Hematology, Erasmus MC Sophia Children s Hospital, Rotterdam, The Netherlands
Pediatr Blood Cancer 49:841-5. 2007..Long-term writing difficulties in children after treatment with vincristine for acute lymphoblastic leukemia, Wilms tumor, B non-Hodgkin lymphoma, and malignant mesenchymal tumors, were investigated...
Renin-induced hypertension in Wilms tumor patientsM H Maas
Department of Pediatric Oncology Hematology, Erasmus MC, Sophia Children s Hospital, Rotterdam, The Netherlands
Pediatr Blood Cancer 48:500-3. 2007..The purpose of this study was to investigate the correlation between plasma renin levels and blood pressure in a larger cohort of WT patients...
T-cell receptor Vbeta CDR3 oligoclonality frequently occurs in childhood refractory cytopenia (MDS-RC) and severe aplastic anemiaA C H de Vries
Department of Pediatric Oncology Hematology, Erasmus University Medical Center Sophia Children s Hospital, Rotterdam, The Netherlands
Leukemia 22:1170-4. 2008..Prospective studies are required to establish the clinical value of TCR Vbeta CDR3 repertoire analysis to predict the clinical response in these patients...
The cryptic chromosomal deletion del(11)(p12p13) as a new activation mechanism of LMO2 in pediatric T-cell acute lymphoblastic leukemiaPieter Van Vlierberghe
Erasmus MC Sophia Children s Hospital, Department of Pediatric Oncology Hematology, 3000 CB Rotterdam, The Netherlands
Blood 108:3520-9. 2006..LMO2 abnormalities represent about 9% (13/138) of pediatric T-ALL cases and are more frequent in pediatric T-ALL than appreciated until now...
Up-regulation of asparagine synthetase expression is not linked to the clinical response L-asparaginase in pediatric acute lymphoblastic leukemiaInge M Appel
Pediatric Oncology/Hematology, Erasmus MC/Sophia Children's Hospital, Rotterdam, PO Box 2060, 3000 CB Rotterdam, The Netherlands
Blood 107:4244-9. 2006..In conclusion, although L-Asp exposure induces the expression of AS mRNA, the up-regulated gene expression does not correlate with an early clinical poor response to this drug in children with ALL...
Decreased PARP and procaspase-2 protein levels are associated with cellular drug resistance in childhood acute lymphoblastic leukemiaAmy Holleman
Erasmus MC/Sophia Children's Hospital, Pediatric Oncology/Hematology, Dr. Molewaterplein 60, 3015 GJ Rotterdam, The Netherlands
Blood 106:1817-23. 2005..In conclusion, low baseline expression of PARP and procaspase-2 is related to cellular drug resistance in childhood acute lymphoblastic leukemia...
No difference between prednisolone and dexamethasone treatment in bone mineral density and growth in long term survivors of childhood acute lymphoblastic leukemiaRobert D van Beek
Department of Pediatric Hematology/Oncology, Erasmus MC-Sophia Children's Hospital, Rotterdam, The Netherlands
Pediatr Blood Cancer 46:88-93. 2006..BMAD was normal after CNS-irradiation. CONCLUSIONS: Long term survivors of ALL treated with prednisolone or dexamethasone containing regimens do not differ in height, BMD, or body composition...
CD34 expression is associated with poor survival in pediatric T-cell acute lymphoblastic leukemiaMartine van Grotel
Department of Pediatric Oncology Hematology, Erasmus University Medical Center Sophia Children s Hospital, Rotterdam, The Netherlands
Pediatr Blood Cancer 51:737-40. 2008....
